Breast MRI Case Review
Focus on DCIS

Recording of a live webinar presented on February 23, 2012

A certified one-hour program with an indepth focus on DCIS for medical imaging and healthcare professionals including: radiologists, interventional radiologists, oncologists, and surgeons.
 

Format:       Archived Webinar
MD Credit:  1.0 AMA PRA Category 1 (Available for physician credit only)
RT Credit:    No ARRT credit available
Fee for Credit Certificate: $0

Click the ENROLL NOW icon to the left to view this program ONLINE.

Course Overview

In the United States, breast cancer is the most common non-skin cancer and the second leading cause of cancer-related death in women.[1] Early detection and treatment can often mean the difference between life and death.

Based on recent evidence on the efficacy of breast magnetic resonance imaging (MRI) screening in high-risk patients, the American Cancer Society (ACS) has issued guidelines for the early detection of breast cancer that include MRI.[2] Additionally, MRI is emerging as an important tool in the treatment of breast cancer patients to evaluate the extent of disease, assess tumor response to neoadjuvant chemotherapy, and for preoperative planning.

This series brings to learners the opportunity to view a variety of breast MRI cases as expert faculty share their experience and approach to breast MRI in their practice.

[1]  Source for incidence and mortality data: Surveillance, Epidemiology, and End Results (SEER) Program and the National Center for Health Statistics.  Available at http://seer.cancer.gov
[2]  Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89.

Educational Objectives for the Series

At the conclusion of this activity, participants should be better able to:

• Develop a systematic strategy to interpret breast MR images and improve diagnostic accuracy
• Use standardized terminology to assess and report breast MRI abnormalities in accordance with ACR BI-RADS® for MRI
• Evaluate the role of morphology and kinetics when assessing a breast lesion
• Apply standard methods and strategies for MRI-guided breast biopsy intervention

Accreditation & Credit

Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and the International Center for Postgraduate Medical Education (ICPME). PIM is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to Participate

You will need a computer with Internet access.  There are no fees or prerequisite for this program.

• Click ENROLL NOW, then CONTINUE, CONFIRM ORDER, and ACCESS COURSE NOW.
• Click the blue link. Complete the precourse evaluation and click SUBMIT.
• Once the precourse evaluation is submitted, click on the blue link again to view the course.
• Click on PLAYBACK. To view the streaming video you may have to download the WebEx Player.

Please note: The WebEx platform will play on desktop or laptop computers only. It will not play on mobile devices.

How to Receive Credit

• Log-in to your account at www.icpme.us
• View the entire one-hour session. The question-and-answer period at the end of the lecture is not required to receive credit.
• At the conclusion of the lecture, close the WebEx Player window. You will be redirected to the ICPME website.
• From the COURSE HOME page, click the buttons for POSTTEST and for EVALUATION.
• A passing grade of at least 75% is required to receive credit.  You may take the test up to three times.
• Upon receipt of a passing grade, click the certificate tab to print a credit certificate.

Faculty Biography

Gillian M. Newstead, MD, FACR
Professor of Radiology, Retired
Senior Research Professional
University of Chicago

Dr. Newstead received her medical degree from the University of Edinburgh in Scotland and completed an internship at Genesee Hospital in Rochester, New York. She then completed a residency in radiology at Strong Memorial Hospital in Rochester and Temple University Hospital in Philadelphia. She is board certified in Radiology by the American College of Radiology.

Dr. Newstead is a member of numerous medical organizations including the American College of Radiology, the Radiological Society of North America, Association for Breast Cancer Control, and the Society for Breast Imaging. She has published more than 50 papers in top medical journals that include Radiology, American Journal of Roentgenology and European Radiology. Dr. Newstead’s awards and honors include being elected to fellowship status by the American College of Radiology, and was voted as the “Attending of the Year”, for excellence in teaching by the residents at the New York University Department of Radiology.

Dr. Newstead’s research interests lie in breast cancer screening, diagnosis and breast MRI. Her work has been supported by grants from the American Cancer Society and the National Cancer Institute.

Disclosure of Conflicts of Interest

The Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty has reported these financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Gillian M. Newstead, MD, FACR has received consulting fees from Bayer HealthCare and holds intellectual property rights and/or is a patent holder from Quantitative Image at the University of Chicago.

The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Sharon Cancino    
Trace Hutchison, PharmD
Samantha Mattiucci, PharmD                
Victoria Phoenix, BS
Lisa Schleelein, MEd
Jan Schultz, RN, MSN, CCMEP
Patricia Staples, MSN, NP-C, CCRN


Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. PIM, ICPME and Hologic, Inc., do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ICPME and Hologic, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Questions
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
Phone: 607-257-5860 x10


Jointly Sponsored by

               
 



This activity is supported by an educational grant from



Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.